These families are also more likely to delay or forgo health care
Read More »HealthDay.com
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
Read More »Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Read More »Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
Read More »Food Companies Race to Replace Artificial Colors With Natural Alternatives
By I. Edwards HealthDay ReporterTUESDAY, April 29, 2025 (HealthDay News) — The push to remove artificial colors from U.S. foods is gaining speed, but making the change won’t be easy — or quick.Last week, U.S. health officials directed food companies to voluntarily phase out petroleum-based synthetic dyes by the end …
Read More »HHS Clarifies: No New Autism Registry Will Be Created
By I. Edwards HealthDay ReporterTUESDAY, April 29, 2025 (HealthDay News) — The U.S. Department of Health and Human Services (HHS) said it will not create a new autism registry, reversing an earlier announcement from the National Institutes of Health (NIH).“We are not creating an autism registry. The real-world data platform …
Read More »AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
Highest incidence-based mortality seen in non-Hispanic Black women, with declines pronounced from 2016, narrowing gap with other racial groups
Read More »AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients
Read More »AACR: Pretrained Machine Learning Models Help Diagnose Nonmelanoma Skin Cancer
Leveraging whole slide embeddings from pretrained machine learning models can improve diagnosis of nonmelanoma skin cancer
Read More »FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.